NAPLEX Quiz: Signs Symptoms And Pathophysiology

What this quiz covers

This quiz focuses on Signs Symptoms And Pathophysiology, giving you a quick way to practice the rules, question types, and explanations that matter most for NAPLEX.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

Question 1

1. Metformin-induced hypoglycemia due to increased insulin secretion
2. Glyburide accumulation in renal impairment causing prolonged hypoglycemia (correct answer)
3. Lisinopril-induced hypoglycemia due to beta-cell stimulation
4. Diabetic ketoacidosis due to absolute insulin deficiency

Explanation: This question assesses medication-related hypoglycemia in diabetes with renal impairment. The key finding is fingerstick glucose of 48 mg/dL with symptoms of shakiness, sweating, and confusion, in a patient with eGFR 22 mL/min/1.73 m^2. Glyburide accumulation in renal impairment causing prolonged hypoglycemia is the best choice because sulfonylureas like glyburide have active metabolites cleared by kidneys, leading to excessive insulin release and low glucose. Metformin doesn't cause hypoglycemia and is not the primary issue, while lisinopril lacks hypoglycemic effects, and diabetic ketoacidosis involves hyperglycemia with acidosis. A transferable insight is preferring shorter-acting sulfonylureas or alternative agents in CKD to avoid hypoglycemia. Clinically, decision-making involves immediate glucose administration and deprescribing high-risk drugs in renal dysfunction.

Question 2

1. Clostridioides difficile infection due to antibiotic-associated disruption of gut flora (correct answer)
2. Acute pancreatitis due to gallstone obstruction
3. Irritable bowel syndrome due to altered gut-brain axis
4. Appendicitis due to luminal obstruction

Explanation: This question tests recognition of antibiotic-associated diarrhea, specifically Clostridioides difficile infection. The key symptoms are watery diarrhea and abdominal cramping following recent clindamycin use, with leukocytosis. Clostridioides difficile infection due to antibiotic-associated gut flora disruption is the best choice because broad-spectrum antibiotics like clindamycin allow C. difficile overgrowth, toxin production, and colitis. Acute pancreatitis presents with epigastric pain and elevated lipase, while irritable bowel syndrome lacks post-antibiotic timing and fever, and appendicitis causes right lower quadrant pain with rebound tenderness. Clinically, testing for C. difficile toxins via PCR or EIA is essential in post-antibiotic diarrhea. A framework includes avoiding high-risk antibiotics in susceptible patients and using fidaxomicin or vancomycin for treatment to reduce recurrence.

Question 3

1. Discontinue metformin immediately because eGFR is <60 mL/min/1.73 m^2
2. Add a sodium-glucose cotransporter-2 (SGLT2) inhibitor with renal and cardiovascular benefit if no contraindications (correct answer)
3. Switch insulin glargine to regular insulin once daily
4. Stop lisinopril to prevent worsening kidney function in diabetes

Explanation: This question tests optimization of therapy in type 2 diabetes with chronic kidney disease and cardiovascular risk, focusing on evidence-based additions. The key lab values are A1C 9.2%, eGFR 38 mL/min/1.73 m^2, and uncontrolled hyperglycemia despite current regimen. Adding an SGLT2 inhibitor is the best choice because it provides glycemic control, renal protection via reduced glomerular hyperfiltration, and cardiovascular benefits in patients with DKD and CAD. Discontinuing metformin is not immediately required as it can be used at eGFR >30 with dose adjustment, while switching to regular insulin lacks rationale and switching off lisinopril would worsen renal outcomes. Stopping lisinopril is inappropriate as ACE inhibitors are nephroprotective in diabetes. A clinical insight is prioritizing agents like SGLT2 inhibitors or GLP-1 agonists in diabetes with comorbidities for multifaceted benefits beyond glucose control. Decision-making should involve assessing eGFR thresholds for medication safety and incorporating cardiorenal protective therapies per guidelines.

Question 4

1. Nitrofurantoin 100 mg by mouth twice daily for 5 days (correct answer)
2. Ciprofloxacin 500 mg by mouth twice daily for 14 days
3. Amoxicillin-clavulanate 875/125 mg by mouth once daily for 3 days
4. Vancomycin 15 mg/kg intravenously every 12 hours for 7 days

Explanation: This question examines the management of uncomplicated cystitis in a young woman, emphasizing first-line antibiotic selection based on guidelines. The key findings are dysuria, frequency, suprapubic discomfort, and positive urine dipstick for leukocyte esterase and nitrites without systemic symptoms. Nitrofurantoin is the best choice because it achieves high urinary concentrations effective against common uropathogens like E. coli, with a short 5-day course minimizing resistance in uncomplicated cases. Ciprofloxacin is reserved for complicated UTIs or resistance due to broader spectrum and resistance concerns, while amoxicillin-clavulanate is not first-line for cystitis and vancomycin is intravenous for resistant infections. A transferable insight is that uncomplicated UTIs in women can often be treated empirically based on local resistance patterns without culture. Clinically, assessing for complicating factors like pregnancy or diabetes guides duration and choice, with follow-up if symptoms persist.

Question 5

1. Omeprazole-induced vitamin K deficiency leading to reduced clotting factor synthesis
2. Warfarin and ibuprofen increasing bleeding risk via anticoagulation plus platelet inhibition and gastrointestinal mucosal injury (correct answer)
3. Warfarin-induced thrombosis due to protein C depletion
4. Ibuprofen causing hemolytic anemia via immune-mediated red blood cell destruction

Explanation: This question assesses identification of drug interactions increasing bleeding risk in a patient on anticoagulation. The key symptoms and labs are dark stools, lightheadedness, INR 3.4, and decreased hemoglobin, following ibuprofen addition to warfarin. Warfarin and ibuprofen interaction is the best choice because ibuprofen inhibits platelets and causes GI mucosal injury, potentiating warfarin's anticoagulation and elevating INR, leading to GI bleeding. Omeprazole-induced vitamin K deficiency is unlikely as it doesn't affect clotting factors directly, while warfarin-induced thrombosis occurs early in therapy, not with supratherapeutic INR. Ibuprofen causing hemolytic anemia would show schistocytes and low haptoglobin, not seen here. Clinically, monitoring INR and avoiding NSAIDs in warfarin patients prevents such interactions, with PPIs for gastroprotection if needed. A framework involves reviewing medication lists for CYP2C9 inhibitors or antiplatelets when bleeding occurs on warfarin.

Question 6

1. Primary hypothyroidism due to autoimmune thyroid destruction
2. Graves disease causing thyroid hormone overproduction (correct answer)
3. Subacute (de Quervain) thyroiditis causing painful thyroid inflammation
4. Secondary hypothyroidism due to pituitary failure

Explanation: This question evaluates recognition of hyperthyroid conditions based on clinical and laboratory findings. The key features are heat intolerance, palpitations, weight loss, tremor, diffusely enlarged thyroid, suppressed TSH (<0.01), and elevated free T4. Graves disease causing thyroid hormone overproduction (B) is correct as it presents with these classic hyperthyroid symptoms plus diffuse goiter due to TSH receptor antibodies stimulating the entire gland. Primary hypothyroidism (A) would show elevated TSH and low T4 with opposite symptoms. Subacute thyroiditis (C) causes a painful, tender thyroid, which this patient lacks. Secondary hypothyroidism (D) would show low TSH and low T4, not elevated T4. The combination of hyperthyroid symptoms, diffuse painless goiter, and biochemical hyperthyroidism strongly suggests Graves disease as the underlying autoimmune etiology.

Question 7

1. Autoimmune demyelination of peripheral nerves triggered by acute infection
2. Chronic hyperglycemia causing microvascular ischemia and oxidative injury to peripheral nerves (correct answer)
3. Acute urate crystal deposition in peripheral joints with secondary nerve compression
4. Excess acetylcholine at the neuromuscular junction leading to muscle fatigue

Explanation: This question assesses understanding of diabetic peripheral neuropathy pathophysiology. The key finding is bilateral burning/tingling pain with decreased sensation in a patient with poorly controlled diabetes (A1c 9.4%). Chronic hyperglycemia causing microvascular ischemia and oxidative injury to peripheral nerves (B) correctly describes the pathophysiology of diabetic neuropathy, where sustained hyperglycemia leads to metabolic and vascular damage to nerve fibers. Autoimmune demyelination (A) describes Guillain-Barré syndrome, which presents acutely with ascending weakness, not chronic sensory symptoms. Acute urate crystal deposition (C) describes gout, which causes joint pain, not neuropathic symptoms. Excess acetylcholine (D) relates to myasthenia gravis, which causes muscle weakness, not sensory neuropathy. The chronic nature, distribution pattern, and association with poor glycemic control confirm diabetic neuropathy as the underlying mechanism.

Question 8

1. Sertraline-induced syndrome of inappropriate antidiuretic hormone secretion (SIADH) causing hyponatremia (correct answer)
2. Acetaminophen-induced acute liver failure causing encephalopathy
3. Hydrochlorothiazide-induced hyperkalemia causing weakness and arrhythmia
4. Sertraline-induced serotonin syndrome causing hyperthermia and clonus

Explanation: This question evaluates the recognition of medication-induced hyponatremia, specifically SIADH from SSRIs in an elderly patient. The key lab value is sodium at 122 mEq/L, with symptoms of confusion, nausea, and unsteady gait following a sertraline dose increase. Sertraline-induced SIADH is the best choice because SSRIs can stimulate inappropriate antidiuretic hormone release, leading to water retention, dilutional hyponatremia, and neurologic symptoms. Acetaminophen-induced liver failure would show elevated liver enzymes and coagulopathy, not isolated hyponatremia, while hydrochlorothiazide-induced hyperkalemia is unlikely with normal potassium and doesn't cause confusion primarily. Sertraline-induced serotonin syndrome presents with hyperthermia, clonus, and autonomic instability, not matching this euvolemic hyponatremia. Clinically, monitoring electrolytes after SSRI initiation or dose changes is crucial in older adults due to higher SIADH risk. A framework for hyponatremia involves assessing volume status and urine osmolality to differentiate causes like SIADH from dehydration or heart failure.

Question 9

1. Add an angiotensin-converting enzyme (ACE) inhibitor to reduce albuminuria and improve blood pressure control (correct answer)
2. Stop hydrochlorothiazide because thiazides are contraindicated when eGFR is <90 mL/min/1.73 m^2
3. Replace amlodipine with short-acting nifedipine for faster blood pressure lowering
4. Add aliskiren as first-line therapy in diabetes with albuminuria

Explanation: This question assesses optimization of antihypertensive therapy in diabetes with albuminuria and suboptimal control. The key findings are average BP 158/92 mmHg and urine albumin-to-creatinine ratio 220 mg/g, with eGFR 58 mL/min/1.73 m^2. Adding an ACE inhibitor is the best choice because it reduces intraglomerular pressure, albuminuria, and BP, providing nephroprotection in diabetic kidney disease. Stopping hydrochlorothiazide is unnecessary as thiazides are effective at eGFR >30, while short-acting nifedipine risks reflex tachycardia, and aliskiren is not first-line due to hyperkalemia risks. Clinically, targeting BP <130/80 mmHg in diabetes involves combination therapy with renin-angiotensin system blockers. A framework includes monitoring potassium and renal function when adding ACE inhibitors to avoid hyperkalemia or AKI.

Question 10

1. Degeneration of dopaminergic neurons in the substantia nigra leading to decreased dopamine in the striatum (correct answer)
2. Autoimmune demyelination of peripheral nerves causing ascending weakness
3. Excess dopamine signaling in the mesolimbic pathway leading to psychosis
4. Acute blockade of acetylcholinesterase causing cholinergic crisis

Explanation: This question evaluates the pathophysiology of neurodegenerative movement disorders based on progressive motor symptoms. The key symptoms are tremor, rigidity, and bradykinesia worsening over a year in an older man. Degeneration of dopaminergic neurons in the substantia nigra is the best choice because it reduces striatal dopamine, causing Parkinson's disease hallmarks like resting tremor and akinesia. Autoimmune demyelination describes Guillain-Barré with weakness, while excess dopamine relates to schizophrenia, and acetylcholinesterase blockade causes toxicity with salivation. Clinically, diagnosis relies on clinical features, with levodopa trials confirming response. A framework includes assessing for non-motor symptoms like depression and using dopamine agonists or levodopa for management.

Question 11

1. Discontinue hydrochlorothiazide and initiate losartan due to gout and hypokalemia risk (correct answer)
2. Increase hydrochlorothiazide to 50 mg daily to improve blood pressure control
3. Add potassium chloride and continue hydrochlorothiazide because it lowers uric acid
4. Switch allopurinol to probenecid because thiazides reduce probenecid efficacy

Explanation: This question assesses understanding of thiazide diuretic adverse effects and appropriate therapeutic modifications. The key findings are uncontrolled hypertension, hypokalemia, hyperuricemia, and recent gout flare in a patient on hydrochlorothiazide. Discontinuing hydrochlorothiazide and initiating losartan due to gout and hypokalemia risk (A) is correct because thiazides worsen both conditions by causing potassium wasting and increasing uric acid reabsorption. Increasing hydrochlorothiazide (B) would worsen both adverse effects. Adding potassium chloride (C) is incorrect because thiazides raise, not lower, uric acid levels. Switching allopurinol to probenecid (D) is inappropriate as probenecid is less effective with reduced GFR and doesn't address the thiazide issue. The clinical decision to switch to an ARB addresses hypertension while avoiding metabolic complications, demonstrating appropriate drug selection based on patient-specific factors.

Question 12

1. Septic arthritis due to bacteremia without systemic symptoms
2. Acute gout flare due to monosodium urate crystal-induced inflammation (correct answer)
3. Osteoarthritis flare due to cartilage degeneration
4. Rheumatoid arthritis due to autoimmune synovitis

Explanation: This question assesses diagnosis of acute gout based on joint symptoms and lab findings in a patient with risk factors. The key symptoms are sudden severe pain, redness, and swelling in the first metatarsophalangeal joint, with elevated uric acid at 9.8 mg/dL. Acute gout flare due to monosodium urate crystal-induced inflammation is the best choice because hyperuricemia leads to crystal deposition in joints, triggering acute synovitis, especially with diuretics like hydrochlorothiazide. Septic arthritis typically involves fever and systemic signs, while osteoarthritis causes chronic pain without acute redness, and rheumatoid arthritis is symmetric with morning stiffness. Clinically, confirming gout via synovial fluid analysis for crystals distinguishes it from mimics like pseudogout. A decision-making framework includes using colchicine or NSAIDs for acute flares and urate-lowering therapy for prevention in recurrent cases.

Question 13

1. Digoxin toxicity precipitated by renal impairment and hypokalemia (correct answer)
2. Serotonin syndrome due to excess serotonergic medications
3. Acute adrenal insufficiency from chronic beta-blocker use
4. Acute opioid intoxication from levothyroxine accumulation

Explanation: This question evaluates recognition of drug toxicity based on clinical presentation and laboratory values. The key findings are confusion, unsteady gait, nausea, bradycardia (HR 52), elevated creatinine, and hypokalemia in a patient taking digoxin. Digoxin toxicity precipitated by renal impairment and hypokalemia (A) is correct because digoxin is renally eliminated, and both renal dysfunction (SCr 1.6) and hypokalemia (K+ 3.1) increase toxicity risk by enhancing cardiac glycoside binding. Serotonin syndrome (B) requires serotonergic medications, which are absent from this regimen. Acute adrenal insufficiency (C) is not caused by beta-blockers and would present with hypotension and hyperkalemia. Option D is nonsensical as levothyroxine doesn't cause opioid effects. The classic triad of neurologic symptoms, GI symptoms, and cardiac effects in the setting of renal impairment and hypokalemia confirms digoxin toxicity.

Question 14

1. Start oral prednisone and add an antibiotic due to increased sputum purulence (correct answer)
2. Start inhaled fluticasone monotherapy for immediate symptom relief
3. Start chronic azithromycin daily as monotherapy for 6 months
4. Start oral theophylline as the preferred acute bronchodilator

Explanation: This question tests management of acute COPD exacerbation based on clinical presentation. The key features are increased dyspnea, wheezing, and purulent sputum in a COPD patient who remains afebrile and hemodynamically stable. Starting oral prednisone and adding an antibiotic due to increased sputum purulence (A) is correct because GOLD guidelines recommend systemic corticosteroids for all COPD exacerbations and antibiotics when sputum purulence increases, indicating bacterial infection. Inhaled fluticasone monotherapy (B) is inadequate for acute exacerbations requiring systemic corticosteroids. Chronic azithromycin (C) is for prevention, not acute treatment. Theophylline (D) is not first-line and has a narrow therapeutic window. The combination of systemic corticosteroids for inflammation reduction and antibiotics for likely bacterial superinfection represents evidence-based management of moderate COPD exacerbation.

Question 15

1. Type I hypersensitivity mediated by immunoglobulin E with mast cell degranulation (correct answer)
2. Type II hypersensitivity with antibody-mediated cytotoxicity against red blood cells
3. Type III hypersensitivity due to immune complex deposition in joints
4. Type IV hypersensitivity mediated by T cells causing delayed contact dermatitis only

Explanation: This question evaluates the immunological mechanism of drug allergies, specifically immediate reactions. The key symptoms are pruritic hives and facial swelling shortly after starting trimethoprim-sulfamethoxazole, without respiratory compromise. Type I hypersensitivity mediated by IgE with mast cell degranulation is the best choice because it involves allergen-IgE binding, releasing histamine and causing urticaria and angioedema. Type II hypersensitivity targets cells like in hemolytic anemia, while type III causes serum sickness with joint involvement, and type IV is delayed without immediate hives. Clinically, discontinuing the offending drug and using antihistamines or epinephrine for severe cases manages anaphylaxis risk. A framework includes documenting allergies and cross-reactivity, such as sulfa drugs, to guide future prescribing.

Question 16

1. Metronidazole 500 mg by mouth twice daily for 7 days
2. Fluconazole 150 mg by mouth once (correct answer)
3. Doxycycline 100 mg by mouth twice daily for 7 days
4. Acyclovir 400 mg by mouth three times daily for 7 days

Explanation: This question examines management of vulvovaginal candidiasis post-antibiotic use in a non-pregnant woman. The key symptoms are vaginal itching and thick, white, cottage cheese-like discharge without odor, following amoxicillin. Fluconazole 150 mg once is the best choice because it inhibits fungal ergosterol synthesis, effectively treating Candida overgrowth from antibiotic-induced flora disruption. Metronidazole targets bacterial vaginosis with malodorous discharge, while doxycycline treats chlamydia, and acyclovir is for herpes without matching symptoms. A transferable insight is recognizing post-antibiotic candidiasis and confirming with wet mount if needed. Clinically, decision-making involves single-dose azoles for uncomplicated cases, with longer courses for recurrence or diabetes.

Question 17

1. Autoantibodies stimulating the thyroid-stimulating hormone receptor leading to increased thyroid hormone production (correct answer)
2. Destruction of thyroid tissue leading to decreased thyroid hormone release
3. Reduced peripheral conversion of T4 to T3 due to deiodinase inhibition
4. Pituitary failure leading to low TSH and low free T4

Explanation: This question assesses the pathophysiology of hyperthyroidism based on symptoms and thyroid labs. The key symptoms are palpitations, heat intolerance, anxiety, and weight loss, with TSH <0.01 mIU/L and high free T4. Autoantibodies stimulating the TSH receptor is the best choice because it describes Graves' disease, leading to unregulated thyroid hormone production and hypermetabolic state. Thyroid destruction causes hypothyroidism, while reduced T4 to T3 conversion occurs in non-thyroidal illness, and pituitary failure yields low TSH with low T4. Clinically, antithyroid drugs like methimazole control hormone synthesis, with beta-blockers for symptom relief. A framework involves measuring thyroid antibodies to confirm autoimmune etiology and monitoring for complications like atrial fibrillation.

Question 18

1. Acute uncomplicated cystitis (correct answer)
2. Acute pyelonephritis
3. Vulvovaginal candidiasis
4. Nephrolithiasis (kidney stone)

Explanation: This question tests the ability to differentiate urinary tract infections from other genitourinary conditions based on clinical presentation. The key symptoms of dysuria, urinary frequency, and suprapubic discomfort without fever or flank pain point to a lower urinary tract infection. Acute uncomplicated cystitis (A) is the best answer as it presents with these classic symptoms in a young, otherwise healthy woman. Acute pyelonephritis (B) would include fever, flank pain, and systemic symptoms, which this patient denies. Vulvovaginal candidiasis (C) typically presents with vaginal discharge and pruritus, which are absent here. Nephrolithiasis (D) would cause severe, colicky flank pain radiating to the groin. The absence of vaginal symptoms and fever, combined with lower urinary tract symptoms, makes uncomplicated cystitis the most likely diagnosis in this premenopausal woman.

Question 19

1. Initiate high-intensity statin therapy for primary prevention given elevated LDL and risk factors (correct answer)
2. Initiate niacin as first-line to raise HDL before considering statins
3. Initiate fenofibrate monotherapy because triglycerides are >150 mg/dL
4. Initiate ezetimibe monotherapy instead of statin due to smoking history

Explanation: This question tests primary prevention of atherosclerotic cardiovascular disease based on lipid profile and risk factors. The key labs are LDL 170 mg/dL, with smoking and hypertension increasing 10-year ASCVD risk. High-intensity statin therapy is the best choice because it reduces LDL by >50%, lowering plaque formation and event risk in high-risk primary prevention. Niacin isn't first-line due to side effects, while fenofibrate targets triglycerides but not LDL primarily, and ezetimibe is adjunctive. A clinical insight is using the ASCVD risk calculator to guide statin intensity. Decision-making involves lifestyle counseling first, then statins, with monitoring for hepatotoxicity or myopathy.

Question 20

1. Acute decompensated heart failure due to fluid overload
2. Community-acquired pneumonia (correct answer)
3. Pulmonary embolism due to venous thromboembolism
4. Stable angina due to myocardial ischemia

Explanation: This question tests the recognition of community-acquired pneumonia based on acute respiratory symptoms and vital signs in a patient with underlying COPD. The key symptoms guiding the diagnosis are fever, productive cough with yellow sputum, pleuritic chest pain, and shortness of breath, accompanied by tachycardia, tachypnea, and hypoxemia. Community-acquired pneumonia is the best choice because it involves bacterial infection of the lung parenchyma causing inflammation, purulent sputum production, and impaired gas exchange, which aligns with the patient's presentation and COPD risk. Acute decompensated heart failure typically presents with orthopnea, edema, and crackles without fever or purulent sputum, while stable angina causes exertional chest pain relieved by rest without infectious signs. Pulmonary embolism often manifests with sudden dyspnea and risk factors like immobility, but lacks productive cough and fever in this context. Clinically, differentiating pneumonia from other causes of dyspnea in COPD patients involves assessing for infection markers like sputum changes to guide antibiotic therapy. A decision-making framework includes using the CURB-65 score to evaluate pneumonia severity and hospitalization needs.